Original language | English |
---|---|
Pages (from-to) | 350-352 |
Number of pages | 3 |
Journal | Science |
Volume | 363 |
Issue number | 6425 |
DOIs | |
State | Published - Jan 25 2019 |
Funding
The viewsexpressed in thispaperarethoseof theauthors and do not reflect theiraffiliated centers or anysponsoring federalagencies.M.B.is supported byNIHR01GM128145. P.H. isco-founder,board member,and equityholder of Microba. K.T.K. is supported byNSF1759831.F.M.is supported byNIH 1R01AI123037-01 and NSF1645609.C.A.O.is supported by Elixir-GR (MIS#5002780)which is funded bytheOperational Programme NSRF2014-2020andcofinancedbyGreece and the European Union.A.A.N.Pis an advisor to LunaDNALLC, Synthetic Genomics and a consultant atOakRidge National Lab.K.S.P.isa consultant forTenaya Therapeutics,Phylagen, and uBiome.